A prescription is not the same as a patient who gets better
There is a number that circulates quietly through the offices of pharmaceutical companies, and it is not a happy one. Somewhere between 60 and 70 percent of patients prescribed a specialty medicine never start it, or stop within a few months. The drug works. The system around it does not. Danny Sigurdson looked hard at that gap and decided it was worth a company.
That company is Courier Health, founded in 2020 and run out of the Flatiron district of New York. Its pitch is straightforward to say and hard to build: give life sciences companies a single platform to engage and support the people taking their therapies, so fewer of them fall out of treatment for reasons that have nothing to do with the medicine itself.
Sigurdson did not come to healthcare from a lab. He came from enterprise software, and the route matters. For more than a decade he sold and built systems that large organizations relied on to run their business. That background shaped a conviction he now repeats to his own team: the product only counts if it moves an outcome.
The number of specialty medicines has exploded over the last decade, forcing the evolution of commercial models to focus on the patient experience.— Danny Sigurdson
From selling software to building it
Before Courier Health, Sigurdson spent his years learning how enterprises actually adopt technology. He was Director of Client Solutions at Applied Predictive Technologies, where he led work helping large companies make data-driven decisions about sales and marketing. That company was acquired by Mastercard in 2015. He then joined ActionIQ as Vice President of Sales, spending roughly five years close to a customer data platform used to deliver personalized experiences at scale.
He studied Economics at Eckerd College, and later completed an executive education program in Digital Transformation in Healthcare at Harvard Medical School - a signal of where his attention was already turning. The common thread across all of it is data: gathering it, connecting it, and turning it into something a business can act on. Courier Health is that instinct pointed at a harder target.
He did not build alone. Courier Health was co-founded with Jimmy Pomponio, who spent more than a decade building and managing patient support programs inside biotech, including leading patient services at Vanda Pharmaceuticals. The pairing is deliberate: a software operator who knows how enterprises buy, and a patient-services veteran who knows where the process breaks.
Focus over appetite
Ask Sigurdson how a young company grows without losing itself and he reaches for a line that has become something of a mantra around the office.
More companies die of indigestion than starvation.— Danny Sigurdson
The point is not modesty. It is that a platform for life sciences could sprawl in a dozen directions, and most of those directions would be a slow way to fail. Courier Health chose to go deep on one thing - the patient experience - and to earn the right to expand from there. The results of that discipline showed up in 2025, when the company quadrupled the number of therapies it manages while doubling its headcount.
His advice to other founders follows the same logic. Stay close to the customer, he says, closer than is comfortable.
Stay maniacally focused on our customers and their outcomes. Get in the trenches with them, understand where their pain points are, and then work tirelessly to deliver the most innovative solution possible.— Danny Sigurdson
Investors bought the thesis, not the hype
Courier Health has raised $70.5 million across three rounds. Work-Bench led a $4 million seed in 2021, having watched Sigurdson operate inside its community during his ActionIQ years. Norwest Venture Partners led a $16.5 million Series A in 2024. Then in 2026 came a $50 million Series B led by Oak HC/FT, with Norwest and Work-Bench following on.
Asked why investors kept writing larger checks, Sigurdson does not credit a pitch deck. He credits arithmetic that happens to be humane.
It ultimately comes down to the scale of the problem, the strength of our platform and team, and most importantly, the outcomes our customers are seeing. What's good for patients is good for business.— Danny Sigurdson
That last sentence is the whole company in nine words. In a lot of businesses, doing right by the customer and doing right by the balance sheet pull against each other. In this one, Sigurdson argues, they point the same way. Every patient who stays on a needed therapy is both a better health outcome and a better commercial result. Alignment, when you can find it, is a durable thing to build on.
The bigger ambition
The framing Sigurdson returns to is not about software categories. It is about the size of the population he thinks is underserved.
One of the most challenging and meaningful opportunities in healthcare is reinventing how the hundreds of millions of people living with rare diseases and chronic conditions are supported.— Danny Sigurdson
It is a large statement from a company of roughly eighty people. But the shape of the bet is clear, and it is consistent with everything else about him: identify a concrete, measurable failure in how the system works, build the narrowest useful tool to fix it, and let the outcomes make the case for going wider.
Away from the numbers, the picture is quieter. He points to Washington Market Park in Tribeca as a place he likes to spend time outdoors with family - a small counterweight to a business built around one of healthcare's more stubborn problems. It fits the pattern of a founder who prefers the specific to the grand, and who would rather earn attention with results than with volume.
The road to Courier Health
Quotable
More companies die of indigestion than starvation.
What's good for patients is good for business.
Get in the trenches with your customers, understand their pain points, and work tirelessly to deliver.
The number of specialty medicines has exploded, forcing commercial models to focus on the patient experience.